Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methohexital Dosage in Electroconvulsive Therapy.

A. J. Bouckoms1, C. A. Welch, L. J. Drop

  • 1Massachusetts General Hospital, Boston, Massachusetts, USA.

Convulsive Therapy
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Wilson's disease, psychosis, and ECT.

Convulsive therapy·1998
Same journal

Maintenance electroconvulsive therapy for Parkinson's disease.

Convulsive therapy·1998
Same journal

Multiple ECT late in the course of neuroleptic malignant syndrome.

Convulsive therapy·1998
Same journal

Prejudice against ECT: competition with psychological philosophies as a contribution to its stigma.

Convulsive therapy·1998
Same journal

Quantifying utilization and practice variation of electroconvulsive therapy.

Convulsive therapy·1998
Same journal

Electroconvulsive therapy consultation: an update.

Convulsive therapy·1998
See all related articles

Methohexital anesthesia for electroconvulsive therapy is safe across a range of doses. Higher doses did not significantly impact blood pressure or seizure duration, indicating flexibility in its clinical use.

Area of Science:

  • Anesthesiology
  • Neurology
  • Psychiatry

Background:

  • Electroconvulsive therapy (ECT) is a vital treatment for severe psychiatric disorders.
  • Anesthesia choice is critical for patient safety during ECT.
  • Methohexital is a commonly used anesthetic agent for ECT.

Purpose of the Study:

  • To compare the safety and efficacy of two different doses of methohexital for anesthesia during unilateral brief pulse ECT.
  • To evaluate the impact of methohexital dosage on hemodynamic stability and seizure duration.

Main Methods:

  • A comparative study involving patients undergoing unilateral brief pulse ECT.
  • Intravenous administration of methohexital at 0.5 mg/kg versus 1 mg/kg.
  • Monitoring of systolic and diastolic blood pressure before, immediately after, and 5 and 10 minutes post-seizure.

Related Experiment Videos

  • Measurement of mean seizure duration.

    • Main Results:

    • No significant differences were observed in systolic or diastolic blood pressure between the two methohexital dosage groups.
    • Hemodynamic parameters remained stable throughout the procedure for both dose groups.
    • Mean seizure duration was not significantly different between the 0.5 mg/kg and 1 mg/kg methohexital groups.

    Conclusions:

    • Methohexital can be safely administered at a broad dosage range (0.5 mg/kg to 1 mg/kg) for anesthesia during unilateral brief pulse ECT.
    • The tested methohexital dosages do not adversely affect blood pressure or seizure duration.
    • These findings support the flexible use of methohexital in ECT anesthesia, prioritizing patient safety.